Table 3

Groups either initiating conversations about advance care plans and recognising a person with MS or PD was dying compared with controls

Community
n (%)
Family
n (%)
GP or GP and family
n (%)
Hospital
n (%)
Nursing home
n (%)
Hospice
n (%)
Patient
n (%)
Advance care planning
 Control population (n=44)3 (6.8)3 (6.8)17 (38.6)4 (9.1)17 (38.6)
 Parkinson’s disease (n=67)4 (6.0)5 (7.5)44 (65.7)9 (13.4)3 (4.5)2 (3.0)
 Multiple sclerosis (n=65)4 (6.2)6 (9.2)32 (49.2)7 (10.8)1 (1.5)3 (4.6)12 (18.5)
Recognition of dying
 Control population (n=45)10 (22.2)2 (4.4)24 (53.3)6 (13.3)3 (6.7)
 Parkinson’s disease (n=62)7 (11.3)38 (61.3)9 (14.5)8 (12.9)
 Multiple sclerosis (n=53)1 (1.9)2 (3.8)34 (64.2)7 (13.2)6 (11.3)3 (5.7)
  • GP, general practitioner; MS, multiple sclerosis; PD, Parkinson's disease.